NovaBay Pharmaceuticals (NBY) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free NBY Stock Alerts $0.12 +0.02 (+20.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 3:49 PM | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call TranscriptMay 12, 2024 | americanbankingnews.comNovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Down 34.2% in AprilMay 8, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals is about to announce earnings — here's what Wall Street expectsApril 17, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesApril 17, 2024 | markets.businessinsider.comBuy Rating Maintained for NovaBay Pharma Amid Strategic Refocus and Resilient Revenue PerformanceMarch 27, 2024 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comQ4 2023 NovaBay Pharmaceuticals Inc Earnings CallMarch 15, 2024 | barrons.comNovaBay Pharmaceuticals Inc.March 14, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals To Sell DERMAdoctor Skincare Business - Quick FactsMarch 13, 2024 | markets.businessinsider.comNovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare ProfessionalsFebruary 26, 2024 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (NBY)January 30, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesJanuary 29, 2024 | msn.comWhy ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketJanuary 9, 2024 | finance.yahoo.comNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkDecember 6, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesNovember 12, 2023 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | benzinga.comRecap: NovaBay Pharmaceuticals Q3 EarningsNovember 9, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNovember 2, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023October 21, 2023 | thestreet.comNovaBay Pharmaceuticals: CEO InterviewOctober 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsOctober 2, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceSeptember 11, 2023 | marketwatch.comNovaBay Pharma Shares Rise 42% After Deal With BioStem TechnologiesSeptember 11, 2023 | markets.businessinsider.comNovaBay Pharma Agrees With BioStem To Commercialize Amniotic Tissue Allograft As Avenova AllograftSeptember 11, 2023 | benzinga.comWhy NovaBay Pharmaceuticals Stock Is Blasting HigherSeptember 11, 2023 | msn.comNovaBay stock soars 86% on optic allograft product dealSeptember 11, 2023 | marketwatch.comNovaBay to Commercialize BioStem Technologies' Amniotic Tissue AllograftSeptember 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftAugust 15, 2023 | finance.yahoo.comNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2023 Earnings Call TranscriptAugust 12, 2023 | msn.comLadenburg Thalmann Maintains Novabay Pharmaceuticals (NBY) Buy RecommendationAugust 11, 2023 | finance.yahoo.comQ2 2023 NovaBay Pharmaceuticals Inc Earnings CallAugust 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAugust 10, 2023 | markets.businessinsider.comNovaBay Pharmaceuticals earnings preview: what Wall Street is expectingAugust 8, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023July 14, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Reports Record Avenova Sales DayJuly 10, 2023 | markets.businessinsider.comNovaBay Pharma: Avenova-Branded Products To Be Available Exclusively During Amazon Prime DayJuly 10, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded ProductsJune 28, 2023 | benzinga.comAnalyst Covering NovaBay Pharmaceuticals Models For 1346% Upside, Issues $12 PT ($NBY)June 28, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Educational Programs and Avenova Product PromotionsJune 20, 2023 | benzinga.comNovaBay Pharmaceuticals Advancing Products Portfolio Earns Analyst Price Target 1638% Higher Than Current ($NBY)June 20, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association CongressJune 12, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Announces DERMAdoctor’s KP Duty Lotion and Scrub Ultra Duo Set for Dry, Rough, Bumpy Skin to be Featured on QVC at a Special PriceJune 2, 2023 | fool.comNovaBay Pharmaceuticals (NYSEMKT: NBY)May 30, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference on May 31 Register NowMay 24, 2023 | proactiveinvestors.comNovaBay Pharmaceuticals looking to grow its three verticals, eye, skin, and wound care in 2023May 24, 2023 | finance.yahoo.comNovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023May 11, 2023 | msn.comNovaBay Pharmaceuticals: Q1 Earnings InsightsMay 11, 2023 | finance.yahoo.comNovaBay Pharmaceuticals Reports First Quarter 2023 Financial ResultsMay 10, 2023 | benzinga.comNovaBay Pharmaceuticals's Earnings: A PreviewMay 5, 2023 | finance.yahoo.comPhaseOne Health Collaborates with Nonprofit Humanitarian Organization to Supply NovaBay Pharmaceuticals’ Phase One® Skin and Wound Cleanser to Ukraine Get NovaBay Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. NBY Media Mentions By Week NBY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBY News Sentiment▼0.800.55▲Average Medical News Sentiment NBY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBY Articles This Week▼30▲NBY Articles Average Week Get NovaBay Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NMTR News APVO News SMFL News AMPE News XSNX News ATHX News ACUR News MOTS News WCUI News SXTC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:NBY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.